By Julia Karow
This story was originally published on August 5.
Illumina and its predecessor Solexa sued Complete Genomics last week, alleging that the human genome sequencing service provider infringes three of Illumina’s patents.
In its complaint, filed Aug. 3 with the US District Court for the District of Delaware, Illumina claims that Complete Genomics infringes US Patents Nos. 6,306,597; 7,232,656; and 7,598,035.